Covidshield gets ready for roll-out

The Central Drugs Standard Control Organisation's Subject Expert Committee (SEC) will be holding a meeting later today (Wednesday) to decide on approving the Covishield vaccine against Covid-19 developed by the Serum Institute of India (SII) and AstraZeneca-Oxford University. The Covishield vaccine is likely to get approval for emergency use in India, said sources. SEC will take the final call on Covishield vaccine on its emergency use authorisation. For more, watch the full show.